newsfilter
← Latest News
GlobeNewswire·

Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying Cognitive Benefits of its "Microdosing" Compounds

Mindset's Family 3 of next-generation psilocybin compounds have demonstrated low levels of activity at the 5-HT2A receptor and long half lives Advancing compounds into additional Proof of Concept preclinical studies to measure daily take-home viabil